RT Journal Article
SR Electronic
T1 Myocardial Viability Does Not Predict Survival Benefit after CABG
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 3
SP 21
OP 21
DO 10.1177/155989771103013
UL http://mdc.sagepub.com/content/11/3/21.abstract
AB Myocardial viability did not predict a survival benefit from surgical revascularization among patients with ischemic heart disease and left ventricular dysfunction, according to the findings of a substudy of the Surgical Treatment for Ischemic Heart Failure Trial [STICH].